This inventor holds 8 USPTO granted patents and 7 published patent applications, plus 3 CIPO patents and 3 EPO patents. Top assignees: Il Dong Pharmaceutical Co., Ltd., Ildong Pharm Co., Ltd., Biosynergen, Inc.. Active years: 2008-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Kangwon-do, KR (2008)
- Gyeonggi-do, KR (2017 - 2022)
- Seoul, KR (2021 - 2024)
- Hwaseong-si, KR (2023 - 2024)
Company Filing History:
Years Active: 2008-2024
Title: The Innovative Contributions of Dong-Keun Song
Introduction
Dong-Keun Song is a prominent inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, holding a total of eight patents. His work focuses on developing compounds that have the potential to address various medical conditions.
Latest Patents
Among his latest patents, Dong-Keun Song has developed autotaxin inhibitor compounds. This patent provides compositions that include autotaxin (ATX) inhibitor compounds, along with methods for using these compounds to inhibit ATX. Additionally, he has created isoxazole derivatives that serve as nuclear receptor agonists. This invention offers methods for treating metabolic diseases, cholestatic liver diseases, or organ fibrosis through the administration of a therapeutically effective amount of a pharmaceutical composition containing isoxazole derivatives.
Career Highlights
Dong-Keun Song has worked with notable companies in the pharmaceutical industry, including Il Dong Pharmaceutical Co., Ltd. and Ildong Pharm Co., Ltd. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Throughout his career, Dong-Keun Song has collaborated with esteemed colleagues such as Yoon-Suk Lee and Kyung-Sun Kim. These partnerships have likely enhanced his research and development efforts in the pharmaceutical sector.
Conclusion
Dong-Keun Song's innovative work in developing pharmaceutical compounds demonstrates his commitment to advancing medical science. His contributions have the potential to significantly impact the treatment of various diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile